CARM insider buying & filings

CARMCarisma Therapeutics Inc.

—

5 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Oct 8 · scanned 18m ago

No price data yet — the yfinance scanner hasn't produced bars for CARM.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Oct 8SELLKlichinsky MichaelChief Scientific Officerdirect56,982 @ $0.2542$14.5K

Oct 8EXERCISEKlichinsky MichaelChief Scientific Officerdirect56,982 @ $0.1100$6.3K

Oct 3SELLKlichinsky MichaelChief Scientific Officerdirect119,347 @ $0.2604$31.1K

Oct 3SELLKlichinsky MichaelChief Scientific Officerdirect200,000 @ $0.2543$50.9K

Oct 3SELLKlichinsky MichaelChief Scientific Officerdirect165,000 @ $0.2570$42.4K

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice